Specify a stock or a cryptocurrency in the search bar to get a summary
ETFMG Treatments, Testing and Advancements ETFGERM
ETFMG Treatments, Testing and Advancements ETF, a constituent of the ETF, is listed on the NYSE ARCA. Its market capitalization stands at 12 524 080 USD. Over the past year, it has generated a yield of -23.00 %. The fund's net expense ratio, a critical measure of operational efficiency, is recorded at 0.68 %. A significant allocation in cash assets underscores its liquidity position and risk management strategy. Turning to technical indicators, they offer a granular perspective on the fund's market behavior, historical trends, and potential forward momentum. For an in-depth analysis get premium access.